Towards implementing value-based healthcare in Dubai: a qualitative framework analysis

Technical Summary: Towards Implementing Value-Based Healthcare in Dubai

Problem Statement
Value-based healthcare (VBHC) aims to reorient health systems from activity-based delivery toward patient-relevant outcomes relative to cost. While Dubai has established several foundational assets for VBHC—including regulatory quality initiatives, condition-specific clinical guidelines (EJADAH), a health information exchange platform (NABIDH), and case-based reimbursement (DRGs)—the specific conditions required to transition these assets into a credible, outcome-informed purchasing system remain underexplored. This is particularly critical in mixed public-private systems like Dubai's, where regulators, payers, providers, and advisors may hold divergent views on accountability, risk, and data use. The study addresses the gap in understanding the practical conditions, implementation tensions, and necessary sequencing for VBHC in this specific regional context.

Methodology
The study employed a qualitative framework analysis to examine stakeholder perspectives on VBHC implementation in Dubai.

• Design: Semi-structured interviews were conducted with 17 purposively sampled stakeholders representing maximum variation across the healthcare system, including regulators, payers (public and private), providers, administrators, and consultants.
• Data Collection: Interviews occurred between June and October 2024, lasting 30–60 minutes. Data were transcribed, de-identified, and analyzed using NVivo 14 Pro.
• Analysis: The study utilized an integrated deductive-inductive coding approach. Deductive coding was informed by established VBHC domains (e.g., outcome measurement, cost attribution, integrated care), while inductive coding captured emerging themes from stakeholder accounts. Data were charted in a framework matrix to identify convergent, divergent, and negative cases across stakeholder groups.
• Reporting: The study adhered to the Consolidated Criteria for Reporting Qualitative Research (COREQ).

Key Results
The analysis identified four interdependent implementation mechanisms that stakeholders view as essential for a credible transition to VBHC:

1. Data Quality as Trust and Accountability: Participants framed data quality not merely as a technical infrastructure challenge but as a governance and trust issue. For outcome-linked reimbursement to be credible, stakeholders require confidence that data is accurate, comparable, risk-adjusted, and used for improvement rather than punitive payment denial. Interoperability (e.g., via NABIDH) is insufficient without standardized outcome definitions, coding rules, and audit processes.
2. Clinical Legitimacy and Standardisation: Clinical standardisation (e.g., via EJADAH) is viewed as necessary for outcome measurement but is contingent on clinician ownership. Stakeholders warned that guidelines imposed without clinician engagement could be perceived as payer-driven cost control, leading to resistance or "compliance-only" behaviors rather than genuine quality improvement.
3. Staged Payment Reform: Payment reform is understood not as an immediate shift from activity-based models to pure value-based models, but as a staged transition. Stakeholders emphasized the need for pilot programs, transparent risk adjustment, and shared governance of indicators before introducing strong financial incentives or penalties. Premature pay-for-quality mechanisms risked disputes, risk selection, and gaming if data credibility and case-mix adjustment were not yet established.
4. Institutionalised Patient-Reported Value: While patient-reported outcome measures (PROMs) and experience measures (PREMs) are recognized as essential, they are currently under-institutionalised. Participants noted that these metrics are often treated as optional engagement tools rather than core components of routine care, performance monitoring, and purchasing decisions.

Key Contributions
The paper's primary contribution is the development of a context-specific Theory of Change (ToC) for VBHC implementation in Dubai. Unlike generic lists of barriers, this ToC posits that VBHC implementation is a sequential, phased process rather than a parallel set of reforms. The model argues that outcome-informed purchasing cannot be credibly introduced unless prior conditions are met in a specific order:

1. Trusted Data Governance: Establishing comparable, risk-adjusted data.
2. Clinically Legitimate Standardisation: Co-designing pathways with clinician ownership.
3. Staged Payment Reform: Piloting outcome-informed reimbursement with transparency before scaling incentives.
4. Operationalised Patient Value: Embedding PROMs/PREMs into routine care and purchasing decisions.

The study reframes data quality as a trust mechanism, clinical standardisation as a legitimacy issue, and payment reform as a transition requiring risk adjustment, rather than simple technical fixes.

Significance and Claims
The paper claims that while Dubai possesses significant assets for VBHC, these will not yield value-based care unless integrated through the proposed sequenced implementation strategy. The significance of the study lies in its empirically informed programme theory, which explains why certain reforms must precede others to ensure the system is governable, professionally acceptable, and operationally feasible.

The authors modestly conclude that the proposed ToC is a hypothesis for future empirical validation. They assert that the model provides a practical foundation for policy development but requires testing in selected clinical conditions to assess its effects on provider behavior, patient outcomes, equity, and expenditure. The study explicitly avoids claiming that VBHC will automatically reduce health expenditures, noting instead that the primary impact should be an enhanced alignment between outcomes, costs, and reimbursement, with expenditure reduction being a potential downstream result dependent on successful implementation. Future research is recommended to test this theory and include direct patient perspectives, which were not captured in this stakeholder-focused study.